Stephenp Robertson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephenp robertson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephenp Robertson Today - Breaking & Trending Today

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 7.1% in May

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 15,520,000 shares, a decrease of 7.1% from the April 30th total of 16,710,000 shares. Based on an average trading volume of 3,110,000 shares, the short-interest ratio […] ....

United States , Stephenp Robertson , Georgem Milne Jr , Royal Bank , Renaissance Technologies , Aurinia Pharmaceuticals Inc , Armistice Capital , News Ratings For Aurinia Pharmaceuticals Daily , Securities Exchange Commission , Aurinia Pharmaceuticals Stock Performance , Bellevue Group , Aurinia Pharmaceuticals , Get Rating , Exchange Commission , Director George , Street Corp , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph ,

Nicolet Advisory Services LLC Invests $152,000 in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)

Nicolet Advisory Services LLC purchased a new position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 18,297 shares of the biotechnology company’s stock, valued at approximately $152,000. Several other hedge funds […] ....

Nova Scotia , United States , Georgem Milne Jr , Stephenp Robertson , Aurinia Pharmaceuticals Inc , Great West Life Assurance Co , Exchange Commission , Nicolet Advisory Services , Royal Bank , News Ratings For Aurinia Pharmaceuticals Daily , Raymond James Associates , Quarter For Aurinia Pharmaceuticals , Blackrock Inc , Vanguard Group Inc , Aurinia Pharmaceuticals Trading Down , Aurinia Pharmaceuticals Company Profile , Vontobel Holding Ltd , Aurinia Pharmaceuticals , Securities Exchange Commission , Get Rating , West Life Assurance , Vanguard Group , Director George , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Visit Holdingschannel ,

Aurinia Pharmaceuticals (AUPH) Set to Announce Earnings on Thursday

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) will be announcing its earnings results before the market opens on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link. Aurinia Pharmaceuticals (NASDAQ:AUPH – Get […] ....

United States , Georgem Milne Jr , Stephenp Robertson , Earnings History For Aurinia Pharmaceuticals , Aurinia Pharmaceuticals Trading Down , Aurinia Pharmaceuticals , Great West Life Assurance Co , Securities Exchange Commission , Group Plc , News Ratings For Aurinia Pharmaceuticals Daily , Ensign Peak Advisors Inc , Aurinia Pharmaceuticals Inc , Geneos Wealth Management Inc , Pricet Rowe Associates Inc , Royal Bank , Get Rating , Pharmaceuticals Trading Down , Director George , Exchange Commission , Wealth Management , West Life Assurance , Peak Advisors Inc , General Group Plc , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph ,

Brokerages Set Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) PT at $12.33

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target […] ....

United States , Stephenp Robertson , Georgem Milne Jr , Aurinia Pharmaceuticals , Analyst Recommendations For Aurinia Pharmaceuticals , International Biotechnology Trust , Institutional Investors Weigh In On Aurinia Pharmaceuticals , Royal Bank , Dupont Capital Management Corp , Aurinia Pharmaceuticals Inc , News Ratings For Aurinia Pharmaceuticals Daily , Tang Capital Management , Aurinia Pharmaceuticals Trading Down , Legacy Advisors , Get Rating , Director George , Capital Management , Biotechnology Trust , Capital Management Corp , Quantbot Technologies , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph ,

NYM (NYM) Self Reported Market Capitalization Tops $77.30 Million

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s share price rose 4.8% on Wednesday . The stock traded as high as $10.74 and last traded at $10.64. Approximately 860,249 shares traded hands during trading, a decline of 75% from the average daily volume of 3,486,144 shares. The stock had previously closed at $10.15. Wall Street […] ....

United States , Stephenp Robertson , Georgem Milne Jr , Aurinia Pharmaceuticals Stock , Bellevue Group , Royal Bank , Aurinia Pharmaceuticals , News Ratings For Aurinia Pharmaceuticals Daily , Armistice Capital , Aurinia Pharmaceuticals Inc , Securities Exchange Commission , Institutional Investors Weigh In On Aurinia Pharmaceuticals , Renaissance Technologies , Get Rating , Director George , Exchange Commission , Street Corp , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph ,